Equities

USANA Health Sciences Inc

USANA Health Sciences Inc

Actions
  • Price (CHF)--
  • Today's Change--
  • Shares traded0.00
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Income statement Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 30 2023202320222021
REVENUE AND GROSS PROFIT
Total revenue9219991,186
OPERATING EXPENSES
Cost of revenue total177194218
Selling, general and admin. expenses, total640686787
Depreciation/amortization------
Unusual expense(income)------
Other operating expenses, total------
Total operating expense8288911,016
Operating income93108170
Other, net0.01(2.59)(2.01)
INCOME TAXES, MINORITY INTEREST AND EXTRA ITEMS
Net income before taxes102109171
Provision for income taxes393954
Net income after taxes6469117
Minority interest------
Net income before extra. Items6469117
Total extraordinary items------
Net income6469117
Inc.avail. to common excl. extra. Items6469117
Inc.avail. to common incl. extra. Items6469117
EPS RECONCILIATION
Basic/primary weighted average shares191920
Basic/primary eps excl. extra items3.313.605.78
Basic/primary eps incl. extra items3.313.605.78
Dilution adjustment------
Diluted weighted average shares191920
Diluted eps excl. extra items3.303.595.73
Diluted eps incl. extra items3.303.595.73
COMMON STOCK DIVIDENDS
DPS - common stock primary issue------
Gross dividend - common stock000
PRO FORMA INCOME
Pro forma net income------
Interest expense, supplemental0.260.190.06
SUPPLEMENTAL INCOME
Depreciation, supplemental111212
Total special items------
NORMALISED INCOME
Normalized income before taxes102109171
Effect of special items on income taxes------
Income tax excluding impact of special items393954
Normalized income after tax6469117
Normalized income avail. to common6469117
Basic normalized EPS3.313.605.78
Diluted normalized EPS3.303.595.73
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.